Rama Al Hamed: Allogeneic SCT in de novo core-binding factor AML in first complete remission

Rama Al Hamed, Hematology/Oncology Fellow at Herbert Irving Comprehensive Cancer Centre, shared on X:

“Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT.

Worse outcomes with consolidation with alloSCT in CR1 compared to ASCT.”

Source: Rama Al Hamed/X

Authors: Rama Al Hamed, Myriam Labopin, Depei Wu, Tobias Gedde-Dahl, Mahmoud Aljurf, Edouard Forcade, Urpu Salmenniemi, Jakob Passweg, Johan Maertens, Thomas Pabst, Jurjen Versluis, Maija Itäla-Remes, Xiao-Jun Huang, Gwendolyn Van Gorkom, Thomas Schroeder, Jaime Sanz, Didier Blaise, Péter Reményi, Urs Schanz, Jordi Esteve, Norbert-Claude Gorin, Fabio Ciceri, Mohamad Mohty

Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT